GL1X · GenesisL1 explorer

Research workbench

First pbz domain of human aplf protein in complex with ribofuranosyladenosine

Analyse First pbz domain of human aplf protein in complex with ribofuranosyladenosine in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2KQD
Type
protein
Length
55 residues
Chains
1
Method
solution nmr
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Aprataxin and pnk-like factor
EC
4.2.99.18
UniProt
Q8IW19
Ligands
ADN, RIB, ZN

Structure

solution nmr · 1 distinct chain · 13% helix, 7% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAprataxin and pnk-like factor (EC 4.2.99.18)protein5513% helix, 7% strandQ8IW19

Ligands and binding sites

  • ADN · Adenosine · ligand · chains A
  • RIB · alpha-D-ribofuranose · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 2KQD · First PBZ domain of human APLF protein in complex with ribofuranosyladenosine · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8IW19 · AlphaFold monomer V2.0 prediction for aprataxin and pnk-like factor (Q8IW19) · a predicted model of the same protein · chain A against A, TM-score 0.54

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.